Results 191 to 200 of about 3,069,601 (247)

Klippel–Trénaunay Syndrome With Pelvic/Rectal and Urinary Bladder Involvement: A Rare Case Report

Clinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT Concurrent bladder and rectosigmoid vascular malformations in Klippel–Trénaunay syndrome can mimic synchronous pelvic malignancy. Multidisciplinary clinical, radiological, endoscopic, and pathological evaluation is essential to avoid misdiagnosis and to guide appropriate, often conservative, management.
Somaya Al Kiswani, Khitam Salahat, Omar Daas, Mohammed AbdulJabbar Abed, Reem Abuhamdah, Usama Al Khuffash, Abdullah Nofal   +6 more
wiley   +1 more source

Cost-effectiveness analysis of disitamab vedotin plus toripalimab versus chemotherapy as first-line treatment for HER2-expressing advanced urothelial cancer. [PDF]

Hum Vaccin Immunother
Xiang Z, Li Z.
europepmc   +1 more source

Cancer‐Related Microangiopathic Haemolytic Anemia Revealing Occult Metastatic Gastrointestinal Signet‐Ring Cell Carcinoma: A Clinicopathological Case Report and Practical Differential Diagnostic Approach

Clinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT This case highlights key laboratory red flags and a failure to respond to standard treatment, both of which should prompt urgent investigation for occult malignancy in patients presenting with cancer‐related microangiopathic hemolytic anemia (CR‐MAHA).
Danijela Jovanovic, Snezana Sretenovic, Dalibor Jovanovic, Milena Ilic, Predrag Djurdjevic   +4 more
wiley   +1 more source

Tremelimumab with or without durvalumab in combination with paclitaxel in metastatic urothelial cancer: phase I/II ICRA trial. [PDF]

Nat Commun
Einerhand SMH, Ali H, Wong SQ, van Dorp J, van Maanen T, de Feijter JM, Montfoort MLV, Boellaard TN, Braaf LM, Brugman W, Vis DJ, Hollander CMJ, Daletzakis A, Schrijver HA, Snapper K, Oosting SF, Bruijnen CP, Wessels LFA, Chan KS, Suelmann BBM, van der Heijden MS.   +20 more
europepmc   +1 more source

Refining risk stratification after indeterminate urinary cytology: Evidence from Bladder EpiCheck

Cancer Cytopathology, Volume 134, Issue 10, October 2026.
Abstract Background This study aimed to evaluate Bladder EpiCheck (BE) performance in detecting urothelial carcinoma (UC) and HG (high‐grade) events in patients with indeterminate cytology and negative cystoscopy. Methods This prospective study included 63 patients who presented with indeterminate urinary cytology and negative cystoscopy between ...
Claudia Mercader, Mercedes Ingelmo‐Torres, Fiorella L. Roldán, Marcel Figueras, Eric Villalba, Pilar Galve, Ignacio Asiaín, Meritxell Costa, Antoni Vilaseca, Josep Oriola, Agustín Franco, Antonio Alcaraz, Lourdes Mengual   +12 more
wiley   +1 more source

Exploring Patient Perspectives on Upper Tract Urothelial Cancer: A Qualitative Interview Study. [PDF]

Oncol Ther
Filipenko D, Acquadro M, Ghatnekar O, Samuelsen CH, Griebsch I.   +4 more
europepmc   +1 more source

Artificial intelligence–assisted digital thyroid FNA cytology: Improved agreement and sensitivity for higher‐risk Bethesda categories with enhanced screening efficiency

Cancer Cytopathology, Volume 134, Issue 10, October 2026.
Abstract Background Accurate cytologic classification of thyroid nodules is essential for clinical management, but interobserver variability and indeterminate interpretations remain persistent challenges. The clinical feasibility of AIxTHY, a disease‐specific deep‐learning algorithm integrated into a digital cytology platform, was evaluated for ...
Swati Satturwar, Zaibo Li, Chi‐Shun Yang, Yi‐Jyun Lin, Wei‐Lei Yang, Ming‐Yu Lin, Cheng‐Hung Yeh, Shih‐Wen Hsu, Yi‐Siou Liu, Guowei Shao, Tien‐Jen Liu, Chih‐Jung Chen, Barbara A. Crothers   +12 more
wiley   +1 more source

Biomarkers for Recurrence and Prognosis in Metastatic Urothelial Cancer: Emerging Clinical Applications. [PDF]

J Cancer
Cendra AS, Ospino LR, Pekarek L, Dbouk Y, Chnaiker S, Luengo A, Villamor T, Corralo A, Diaz-Pedrero R, Lopez-Gonzalez L, Saez MA, Alhaddadin MNM, Alonso-Bartolome MB, Casanova-Martín C, Alvarez-Mon M, Rodriguez LG, Barrena-Blázquez S, Ortega MA.   +17 more
europepmc   +1 more source

Extended Versus Non‐Extended Lymphadenectomy in Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta‐Analysis

Journal of Surgical Oncology, Volume 134, Issue 5, Page 617-630, October 2026.
ABSTRACT Pelvic lymph node dissection is an essential component of radical cystectomy (RC) for bladder cancer (BC), but the optimal extent of lymphadenectomy remains uncertain. We conducted a systematic review and meta‐analysis to compare oncologic and perioperative outcomes between extended and non‐extended lymphadenectomy during RC for BC.
Maria Fernanda Dias Azevedo, Pedro Henrique Souza Brito, Lucas Kallas‐Silva, Bruno Liebl, Beatriz Taveira Constantinou, Bianca Caroline Benedicto, Lucas Paschoalino de Oliveira, Mauricio Dener Cordeiro, William Carlos Nahas, Walid Shabana, Walid Shahrour, Leopoldo Alves Ribeiro‐Filho, Caio Vinicius Suartz   +12 more
wiley   +1 more source

Oncologic outcome and safety profile of first-line enfortumab vedotin plus pembrolizumab vs. conventional chemotherapy in advanced urothelial cancer. [PDF]

Explor Target Antitumor Ther
Miyake M, Nishimura N, Oda Y, Shimizu T, Inoue T, Anai S, Sakamoto K, Matsumura Y, Toyoshima Y, Ichii D, Iida K, Iwamoto T, Takamatsu N, Tomioka A, Yamamoto H, Maesaka F, Fujimoto K, Nara Urological Research Treatment Group.   +17 more
europepmc   +1 more source